Dr. Sheldon Kardener discusses his experience as the first patient to undergo the procedure (July 2018) of inserting Abbott’s next-generation version of the company’s leading MitraClip® heart valve repair device in the U.S. This minimally invasive option, allowed him to return home a mere two days after his procedure and let him get back to his daily activities, like teaching and exercising, more quickly.
To view the transcript of this interview, visit www.hpr.fm
